EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Ototoxicity and cognitive outcomes among very young children treated for brain tumors: Findings from a multisite, prospective, longitudinal trial

Heather M Conklin iD, Nicole A Salman, Johnnie K Bass, Jie Huang, Arzu Onar-Thomas iD, Jason M Ashford, Jennifer Harman, Jeanelle S Ali, Michelle A Swain, Lana L Harder, Bonnie L Carlson-Green, Jonathan M Miller und 5 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf073 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Heather M Conklin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Ototoxicity, Hearing Loss, Sensorineural, Cognition. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, American Lebanese Syrian Associated Charities, St. Jude Cancer Center Support.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brain tumor treatment can result in sensorineural hearing loss (SNHL) that is associated with cognitive declines in school-age children. Young children treated for brain tumors are at heightened cognitive risk. This study examines the unique contribution of treatment-related ototoxicity to cognitive outcomes in young children treated for brain tumors.

Methods

135 young children (mean age = 1.7 years) with a newly diagnosed malignant brain tumor were treated with chemotherapy, with or without focal proton or photon radiation therapy. Serial audiology and neurocognitive assessments were conducted for 5 years as part of a prospective, multisite, longitudinal trial (SJYC07; NCT00602667). SNHL was dichotomized as present versus not present (Chang grade ≥1a vs. 0). Neurocognitive assessments included intellectual functioning and parent ratings of adaptive functioning and attention.

Results

67% of patients experienced mild-to-severe SNHL, which was associated with younger age at diagnosis (P < .001) but not sex, treatment, or study risk arm (P > .10). Pre-treatment, higher intelligence quotient (IQ) was associated with older age and higher socioeconomic status (P < .01), with a negative change in IQ trajectory after SNHL that was worse for children with supratentorial tumors. Pre-treatment, higher adaptive functioning was associated with older age (P = .0001), with a negative change in adaptive functioning trajectory after SNHL that was worse for those treated at a younger age. Attention problems increased after SNHL for the entire group (P = .0099).

Conclusions

SNHL is associated with IQ decline and worsening adaptive functioning and attention in young children treated for brain tumors. These findings have important implications for treatment modifications, interventions, and caregiver education.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsOtotoxicityHearing Loss, SensorineuralCognitionCognition DisordersHumansFemaleMaleChild, PreschoolProspective StudiesLongitudinal StudiesInfantChildFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

brain tumorcognitive outcomesototoxicitypediatric oncologyyoung child

Autor:innen und Institutionen

  • Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Rehabilitation Services, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Oncology Services Group, Queensland Children's Hospital, South Brisbane, Queensland, Australia.
  • Department of Pediatric Psychiatry and Psychology, Children's Medical Center Dallas, Dallas, Texas, USA.
  • Department of Pediatric Neuropsychology, Children's Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Heather M Conklin, Arzu Onar-Thomas, Thomas E Merchant, Amar Gajjar

Förderung

  • NCI NIH HHS
  • American Lebanese Syrian Associated Charities
  • St. Jude Cancer Center Support
  • National Cancer Institute

Zitieren

APA

Conklin, H. M., Salman, N. A., Bass, J. K., Huang, J., Onar-Thomas, A., Ashford, J. M., Harman, J., Ali, J. S., Swain, M. A., Harder, L. L., Carlson-Green, B. L., Miller, J. M., Wallace, J., Kaner, R. J., Merchant, T. E., Robinson, G. W., & Gajjar, A. (2025). Ototoxicity and cognitive outcomes among very young children treated for brain tumors: Findings from a multisite, prospective, longitudinal trial. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf073

Vancouver

Conklin HM, Salman NA, Bass JK, Huang J, Onar-Thomas A, Ashford JM, et al. Ototoxicity and cognitive outcomes among very young children treated for brain tumors: Findings from a multisite, prospective, longitudinal trial. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf073

BibTeX
@article{Conklin2025,
  author = {Conklin, Heather M and Salman, Nicole A and Bass, Johnnie K and Huang, Jie and Onar-Thomas, Arzu and Ashford, Jason M and Harman, Jennifer and Ali, Jeanelle S and Swain, Michelle A and Harder, Lana L and Carlson-Green, Bonnie L and Miller, Jonathan M and Wallace, Joanna and Kaner, Ryan J and Merchant, Thomas E and Robinson, Giles W and Gajjar, Amar},
  title = {Ototoxicity and cognitive outcomes among very young children treated for brain tumors: Findings from a multisite, prospective, longitudinal trial},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf073}
}
Kostenlos starten →